Published on: March 7th, 2018 • Duration: 20 minutes
More than a decade has passed since the first human genome was mapped. Since then, costs have plunged and major efficiencies have been achieved. Cathie Wood, founder and CEO of Ark Invest, tells us about investment opportunities in CRISPR and CAR-T technology, the major drivers of the genomics revolution. Filmed on February 20th, 2018.